Creative Financial Designs’s ADMA Biologics ADMA Stock Holding History

Creative Financial Designs’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,000	Closed	-$22.4K	–	1679
2024 Q2	$22.4K	Hold	2,000	–	–	﹤0.01%	967
2024 Q1	$13.2K	Hold	2,000	–	–	﹤0.01%	1067
2023 Q4	$9.04K	Hold	2,000	–	–	﹤0.01%	1117
2023 Q3	$7.16K	Hold	2,000	–	–	﹤0.01%	1111
2023 Q2	$7.38K	Hold	2,000	–	–	﹤0.01%	1099
2023 Q1	$6.62K	Hold	2,000	–	–	﹤0.01%	1050
2022 Q4	$7.76K	Hold	2,000	–	–	﹤0.01%	945
2022 Q3	$5K	Hold	2,000	–	–	﹤0.01%	1017
2022 Q2	$4K	Hold	2,000	–	–	﹤0.01%	1022
2022 Q1	$4K	Hold	2,000	–	–	﹤0.01%	1060
2021 Q4	$3K	Hold	2,000	–	–	﹤0.01%	1071
2021 Q3	$2K	Hold	2,000	–	–	﹤0.01%	1282
2021 Q2	$3K	Hold	2,000	–	–	﹤0.01%	1251
2021 Q1	$4K	Hold	2,000	–	–	﹤0.01%	1080
2020 Q4	$4K	Hold	2,000	–	–	﹤0.01%	1006
2020 Q3	$5K	Buy	+2,000	New	+$5.48K	﹤0.01%	910

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Creative Financial Designs's ADMA Position: Q3 2024 in Review

Creative Financial Designs sold out of ADMA Biologics (ADMA) in Q3 2024, closing a stake of 2,000 shares — an estimated $22.4K sold.

Creative Financial Designs first reported a position in ADMA in Q3 2020 and held it in 16 quarters. The position peaked at $22.4K in Q2 2024. 306 funds tracked by Wall St. Rank hold ADMA as of Q3 2024.

Creative Financial Designs reported no remaining ADMA Biologics position as of Q3 2024 after selling out during the quarter.
Creative Financial Designs sold 2,000 ADMA Biologics shares in Q3 2024, an estimated $22.4K.
Creative Financial Designs first reported a position in ADMA Biologics in Q3 2020 and held it in 16 quarters.
Creative Financial Designs's ADMA Biologics position peaked at $22.4K in Q2 2024.
306 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2024.

Based on Creative Financial Designs's 13F filing for Q3 2024, filed 28 Oct 2024.